Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study
Kort samengevat
Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study Study supporting the approval of Nyxoah's Genio® system in the U.S. to be initiated in the coming months
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Benzinga.
Lees het volledige bericht ↗